Safety of continuous periprocedural rivaroxaban for patients undergoing left atrial catheter ablation procedures.


BACKGROUND This study aimed to evaluate the safety of continuous periprocedural rivaroxaban administration during left atrial radiofrequency ablation (RFA) in comparison with uninterrupted oral vitamin K antagonist administration. Data about the use of rivaroxaban in the setting of left atrial RFA procedures are lacking. METHODS AND RESULTS The study… (More)
DOI: 10.1161/CIRCEP.114.001586


4 Figures and Tables

Slides referencing similar topics